AI is revolutionizing the drug design process by using machine learning and data analysis to quickly identify promising compounds, accelerate validation of drug targets,…
Browsing: Drug Design
Dyno Therapeutics and NVIDIA are collaborating to advance biological sequence design using Dyno’s AI and in vivo experimentation capabilities and NVIDIA’s BioNeMo platform. This…
This article discusses the potential use of quantum computing in the pharmaceutical industry for drug design. It explains the current challenges and limitations in…
This Special Issue explores the application of deep learning and machine learning techniques in drug design and discovery, showcasing cutting-edge research at the intersection…
This Special Issue aims to present an overview of recent advances in computational modeling, machine learning, and deep learning to identify therapeutic targets, candidate…
Exponential growth in technology is often difficult to comprehend, but it is evident in the development of AI and quantum computing. Google’s 53-qubit machine…
Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, will be held March 25-28 in Seattle. Experts will discuss…
In this interview, Xudong Lv, the co-founder of QuanMol Tech, reveals that his research in quantum physics has led to an important discovery in…